down arrow

Sanofi India

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE058A01010
  • NSEID: SANOFI
  • BSEID: 500674
INR
4,335.85
-35.85 (-0.82%)
BSENSE

Dec 05

BSE+NSE Vol: 50.14 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Net Sales
1,498.30
1,526.80
Other Operating Income
0.00
0.00
Total Operating income
1,498.30
1,526.80
Raw Material Cost
252.10
265.60
Purchase of Finished goods
325.80
765.50
(Increase) / Decrease In Stocks
151.60
-297.00
Employee Cost
186.40
208.30
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
209.90
196.50
Total Expenditure (Excl Depreciation)
1,125.80
1,138.90
Operating Profit (PBDIT) excl Other Income
372.50
387.90
Other Income
10.60
51.90
Operating Profit (PBDIT)
383.10
439.80
Interest
1.10
1.30
Exceptional Items
53.90
188.10
Gross Profit (PBDT)
336.30
456.30
Depreciation
27.10
27.20
Profit Before Tax
309.20
429.10
Tax
86.80
134.20
Provisions and contingencies
0.00
0.00
Profit After Tax
222.40
294.90
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
99.60
170.30
Net Profit
322.00
465.20
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
322.00
465.20
Equity Capital
23.00
23.00
Face Value
10.0
10.0
Reserves
0.00
0.00
Diluted Earnings per share
35.69
65.95
Operating Profit Margin (Excl OI)
24.86%
25.41%
Gross Profit Margin
22.45%
29.89%
PAT Margin
14.84%
19.31%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Sep 2025 is -5.39% vs -1.87% in Sep 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Sep 2025 is -17.75% vs -30.78% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Sep 2025 is 7.65% vs -3.97% in Sep 2024

stock-summary

Interest

YoY Growth in nine months ended Sep 2025 is 0.00% vs -15.38% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Sep 2025 has improved from Sep 2024

Compare Nine Monthly Results Of Sanofi India With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,498.30
0
1,498.30
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,498.30
0
1,498.30
Raw Material Cost
252.10
0
252.10
Purchase of Finished goods
325.80
0
325.80
(Increase) / Decrease In Stocks
151.60
0
151.60
Employee Cost
186.40
0
186.40
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
209.90
0.00
209.90
Total Expenditure (Excl Depreciation)
1,125.80
0
1,125.80
Operating Profit (PBDIT) excl Other Income
372.50
0.00
372.50
Other Income
10.60
0
10.60
Operating Profit (PBDIT)
383.10
0
383.10
Interest
1.10
0
1.10
Exceptional Items
53.90
0
53.90
Gross Profit (PBDT)
336.30
0
336.30
Depreciation
27.10
0
27.10
Profit Before Tax
309.20
0
309.20
Tax
86.80
0
86.80
Provisions and contingencies
0.00
0
0.00
Profit After Tax
222.40
0
222.40
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
99.60
0
99.60
Net Profit
322.00
0
322.00
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
322.00
0
322.00
Equity Capital
23.00
0
23.00
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
22.45%
0.00%
0.00
22.45%
PAT Margin
14.84%
0.00%
0.00
14.84%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,417.60 Cr
in Sep 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Sep 2025 is -5.39% vs -1.87% in Sep 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 265.00 Cr
in Sep 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Sep 2025 is -17.75% vs -30.78% in Sep 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 401.00 Cr
in Sep 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Sep 2025 is 7.65% vs -3.97% in Sep 2024

Nine Monthly - Interest
Interest 1.10 Cr
in Sep 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Sep 2025 is 0.00% vs -15.38% in Sep 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.29%
in Sep 2025

Figures in %
stock-summary

YoY Growth in nine months ended Sep 2025 has improved from Sep 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."